The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-((2-fluoro-4-iodophenyl)amino)phenyl)(4-methylpiperazin-1-yl)methanone ID: ALA4127200
PubChem CID: 117955916
Max Phase: Preclinical
Molecular Formula: C18H19FIN3O
Molecular Weight: 439.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(C(=O)c2ccccc2Nc2ccc(I)cc2F)CC1
Standard InChI: InChI=1S/C18H19FIN3O/c1-22-8-10-23(11-9-22)18(24)14-4-2-3-5-16(14)21-17-7-6-13(20)12-15(17)19/h2-7,12,21H,8-11H2,1H3
Standard InChI Key: LLPCMEOKPPPYJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
11.7755 -8.4138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0610 -8.0013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -9.2388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4900 -9.6513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4900 -10.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -10.8888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0610 -10.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0610 -9.6513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -11.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4900 -8.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4900 -7.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2045 -6.7638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9189 -7.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9189 -8.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2045 -8.4138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -6.7638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -5.9388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0610 -5.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0610 -4.7013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -4.2888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4900 -4.7013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4900 -5.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7755 -3.4638 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
10.3466 -5.9388 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
3 8 1 0
6 9 1 0
1 3 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
20 23 1 0
18 24 1 0
16 17 1 0
11 16 1 0
1 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 439.27Molecular Weight (Monoisotopic): 439.0557AlogP: 3.56#Rotatable Bonds: 3Polar Surface Area: 35.58Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.85CX LogP: 4.93CX LogD: 4.82Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.74Np Likeness Score: -1.95
References 1. Chakrabarty S, Monlish DA, Gupta M, Wright TD, Hoang VT, Fedak M, Chopra I, Flaherty PT, Madura J, Mannepelli S, Burow ME, Cavanaugh JE.. (2018) Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways., 28 (13): [PMID:29803729 ] [10.1016/j.bmcl.2018.05.029 ]